A Trial Investigating the Pharmacodynamic Response of FIAsp in Subjects With Type 1 Diabetes

Trial Profile

A Trial Investigating the Pharmacodynamic Response of FIAsp in Subjects With Type 1 Diabetes

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 15 Feb 2017 Results of post hoc analysis from pooled data of six trials (NCT02035371, NCT01924637, NCT02131246, NCT02033239, NCT02003677 and NCT01618188) published in the Clinical Pharmacokinetics
    • 22 Nov 2016 Results published in the Clinical Pharmacokinetics.
    • 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top